Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Hassoun
    Hassoun
  3. Hultcrantz
    Hultcrantz
  4. Korde
    Korde
  5. Lesokhin
    Lesokhin
  6. Mailankody
    Mailankody
  7. Shah
    Shah
  8. Chung
    Chung
  9. Derkach
    Derkach
  10. Iyengar
    Iyengar

Groups

  1. Breast Medicine Service (5)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. Hematologic Malignancies, Division of (5)
  5. Sloan Kettering Institute Postdocs (5)
  6. Solid Tumor Oncology Division (5)
  7. Survivorship Research (5)
  8. Biostatistics Service (4)
  9. Bone Marrow Transplant (4)
  10. CTCR Scholars (4)
Search Within
  1. "Clinical Lymphoma, Myeloma and Leukemia"
  2. "Breast Medicine Service"
Formats
  1. Meeting Abstract (4)
  2. Research Letter (1)
Groups
  1. Breast Medicine Service (5)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. Hematologic Malignancies, Division of (5)
  5. Sloan Kettering Institute Postdocs (5)
  6. Solid Tumor Oncology Division (5)

More Groups

People
  1. Alexander Lesokhin (4)
  2. Hani Hassoun (4)
  3. Malin Hultcrantz (4)
  4. Neha Korde (4)
  5. Sergio Giralt (4)
  6. Sham Mailankody (4)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (1)
  5. 2017 (1)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Providing nutritional guidance for patients with plasma cell disorders - A missed opportunity for hematologists and oncologists?
    Meeting Abstract

    Sweeney, N.; Malik, M.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P.; Mailankody, S.; Korde, N.; Tan, C.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Phase I study of selinexor, ixazomib, and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma
    Research Letter

    Salcedo, M.; Lendvai, N.; Mastey, D.; Schlossman, J.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era treated at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P.; Horwitz, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save